Interventions for Tuberculosis Control and Elimination 2002

514. British Thoracic Association. A controlled trial of six months chemotherapy in
pulmonary tuberculosis. Second report: results during the 24 months after the
end of chemotherapy. Am Rev Respir Dis 1982; 126: 460-2.
515. British Thoracic Society. A controlled trial of 6 months’ chemotherapy in pulmonary
tuberculosis. Final report: results during the 36 months after the end of
chemotherapy and beyond. Br J Dis Chest 1984; 78: 330-6.
516. Mehrotra ML, Gautam KD, Chaube CK. Shortest possible acceptable, effective
ambulatory chemotherapy in pulmonary tuberculosis: preliminary report I.
Rev Respir Dis 1981; 124: 239-44.
Am
517. Mehrotra ML, Gautam KD, Chaube CK. Shortest possible acceptable effective
chemotherapy in ambulatory patients with pulmonary tuberculosis. Part II. Results
during the 24 months after the end of chemotherapy.
129: 1016-7.
Am Rev Respir Dis 1984;
518. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy
and management of tuberculosis in the United Kingdom: recommendations 1998.
Thorax 1998; 53: 536-48.
519. East African Medical Research Council, British Medical Research Council.
Controlled clinical trial of four short-course regimens of chemotherapy for two
durations in the treatment of pulmonary tuberculosis. First report. Third East
African/British Medical Research Councils Study.
39-48.
Am Rev Respir Dis 1978; 118:
520. East African Medical Research Council, British Medical Research Council.
Controlled clinical trial of four short-course regimens of chemotherapy for two
durations in the treatment of pulmonary tuberculosis. Second report. Third East
African/British Medical Research Council Study. Tubercle 1980; 61: 59-69.
521. Tuberculosis Research Centre Chennai. A controlled clinical trial of oral shortcourse
regimens in the treatment of sputum-positive pulmonary tuberculosis.
J Tuberc Lung Dis 1997; 1: 509-17.
Int
522. Mathew R, Santha T. The treatment of WHO Category 1 tuberculosis with
2HRZE/6EH is indeed defensible.
4: 795.
(Counterpoint). Int J Tuberc Lung Dis 2000;
523. Tuberculosis Chemotherapy Centre Madras. A concurrent comparison of intermittent
(twice-weekly) isoniazid plus streptomycin and daily isoniazid plus PAS
in the domiciliary treatment of pulmonary tuberculosis.
1964; 31: 247-71.
Bull World Health Organ
524. Cohn DL, Catlin BJ, Peterson KL, Judson FN, Sbarbaro JA. A 62-dose, 6-month
therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly
observed, and cost-effective regimen. Ann Intern Med 1990; 112: 407-15.
525. Snider DE, Rogowski J, Zierski M, Bek E, Long MW. Successful intermittent
treatment of smear-positive pulmonary tuberculosis in six months: a cooperative
study in Poland. Am Rev Respir Dis 1982; 125: 265-7.
203